ID   SW4#N1
AC   CVCL_B5RD
SY   SW4 #N1; ND2 LV#NI
DR   Wikidata; Q112041745
RX   PubMed=22308265;
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RE ! SW4#SE
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=22308265; DOI=10.18632/aging.100428; PMCID=PMC3292906;
RA   Ohmine S., Squillace K.A., Hartjes K.A., Deeds M.C., Armstrong A.S.,
RA   Thatava T., Sakuma T., Terzic A., Kudva Y.C., Ikeda Y.;
RT   "Reprogrammed keratinocytes from elderly type 2 diabetes patients
RT   suppress senescence genes to acquire induced pluripotency.";
RL   Aging (Albany N.Y.) 4:60-73(2012).
//
RX   PubMed=23197849; DOI=10.5966/sctm.2011-0044; PMCID=PMC3652675;
RA   Kudva Y.C., Ohmine S., Greder L.V., Dutton J.R., Armstrong A.S.,
RA   De Lamo J.G., Khan Y.K., Thatava T., Hasegawa M., Fusaki N.,
RA   Slack J.M.W., Ikeda Y.;
RT   "Transgene-free disease-specific induced pluripotent stem cells from
RT   patients with type 1 and type 2 diabetes.";
RL   Stem Cells Transl. Med. 1:451-461(2012).
//